The North America Nerve Repair and Regeneration Market would witness market growth of 6.0% CAGR during the forecast period (2022-2028).
The brain, spinal cord, and peripheral nerves, which make up the nervous system, are vulnerable to a variety of injuries, from trauma to neurodegenerative diseases which cause progressive deterioration, such as Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis, and multiple system atrophy.
However, due to the brain's and spinal cord's complexity, little spontaneous regeneration, repair, or healing occurs. As a result, brain damage, spinal cord paralysis, and peripheral nerve damage are frequently permanent and incapacitating. Patients who have suffered catastrophic nervous system injuries or strokes frequently require lifelong care, placing a significant financial and social burden on the patients, their families, and society. To progress the treatment of neurological damage, novel, paradigm-shifting treatments are necessary.
In Canada, the rise in the cases of neurological issues along with the supportive healthcare insurance coverage would create demand for innovative medical practices across the region. Another important reason in this regional market is the availability of technologically advanced equipment. As per the Alzheimer's Association, the number of people living with Alzheimer's disease in the United States is rapidly increasing. In 2019, more than 5 million Americans of all generations were diagnosed with Alzheimer's disease. In 2020, an approximate 5.8 million Americans aged 65 and up will be diagnosed with Alzheimer's disease. Eighty percent of the population is 75 years old or older. Alzheimer's dementia affects one out of every ten adults over the age of 65 (10%). Women account for about two-thirds of Alzheimer's patients in the United States. Furthermore, rising government initiatives and financing, as well as an increase in cases of neurological illnesses like dementia, Alzheimer's disease, and Parkinson's disease, are all contributing factors.
The US market dominated the North America Nerve Repair and Regeneration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,860.5 Million by 2028. The Canada market is experiencing a CAGR of 8.4% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 7.5% during (2022 - 2028).
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Nerve Repair and Regeneration Market is Estimated to reach $9.4 Billion by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Surgery
- Neuromodulation Surgery
- Direct Neuropathy
- Nerve Grafting
- Stem Cell Therapy
By Product
- Neuromodulation Surgery Devices
- Biomaterials
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Integra Lifesciences Corporation
- Medtronic PLC
- Axogen, Inc.
- Stryker Corporation
- Checkpoint Surgical, Inc.
- Polyganics BV
- Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
- OrthoMed, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nerve Repair and Regeneration Market, by Surgery
1.4.2 North America Nerve Repair and Regeneration Market, by Product
1.4.3 North America Nerve Repair and Regeneration Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Nerve Repair and Regeneration Market by Surgery
4.1 North America Neuromodulation Surgery Market by Country
4.2 North America Direct Neuropathy Market by Country
4.3 North America Nerve Grafting Market by Country
4.4 North America Stem Cell Therapy Market by Country
Chapter 5. North America Nerve Repair and Regeneration Market by Product
5.1 North America Neuromodulation Surgery Devices Market by Country
5.2 North America Biomaterials Market by Country
Chapter 6. North America Nerve Repair and Regeneration Market by Country
6.1 US Nerve Repair and Regeneration Market
6.1.1 US Nerve Repair and Regeneration Market by Surgery
6.1.2 US Nerve Repair and Regeneration Market by Product
6.2 Canada Nerve Repair and Regeneration Market
6.2.1 Canada Nerve Repair and Regeneration Market by Surgery
6.2.2 Canada Nerve Repair and Regeneration Market by Product
6.3 Mexico Nerve Repair and Regeneration Market
6.3.1 Mexico Nerve Repair and Regeneration Market by Surgery
6.3.2 Mexico Nerve Repair and Regeneration Market by Product
6.4 Rest of North America Nerve Repair and Regeneration Market
6.4.1 Rest of North America Nerve Repair and Regeneration Market by Surgery
6.4.2 Rest of North America Nerve Repair and Regeneration Market by Product
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Approvals and Trials:
7.3 Boston Scientific Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.5.2 Approvals and Trials:
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisitions and Mergers:
7.6 Axogen, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expenses
7.6.4 Recent strategies and developments:
7.6.4.1 Approvals and Trials:
7.7 Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 OrthoMed, Inc.
7.8.1 Company Overview
7.9 Polyganics BV
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Geographical Expansions:
7.10. Checkpoint Surgical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Acquisition and Mergers:
7.10.2.3 Approvals and Trials:
TABLE 1 North America Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 2 North America Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Nerve Repair and Regeneration Market
TABLE 4 Product Launches And Product Expansions– Nerve Repair and Regeneration Market
TABLE 5 Acquisition and Mergers– Nerve Repair and Regeneration Market
TABLE 6 Approvals and trials- Nerve Repair and Regeneration Market
TABLE 7 Geographical Expansions- Nerve Repair and Regeneration Market
TABLE 8 North America Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 9 North America Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 10 North America Neuromodulation Surgery Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Neuromodulation Surgery Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Direct Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Direct Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Nerve Grafting Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Nerve Grafting Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 19 North America Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 20 North America Neuromodulation Surgery Devices Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Neuromodulation Surgery Devices Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Biomaterials Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Biomaterials Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Nerve Repair and Regeneration Market by Country, 2018 - 2021, USD Million
TABLE 25 North America Nerve Repair and Regeneration Market by Country, 2022 - 2028, USD Million
TABLE 26 US Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 27 US Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 28 US Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 29 US Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 30 US Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 31 US Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 32 Canada Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 33 Canada Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 34 Canada Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 35 Canada Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 36 Canada Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 37 Canada Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 38 Mexico Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 39 Mexico Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 40 Mexico Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 41 Mexico Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 42 Mexico Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 43 Mexico Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 44 Rest of North America Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 45 Rest of North America Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 46 Rest of North America Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 47 Rest of North America Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 48 Rest of North America Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 49 Rest of North America Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 50 Key Information – Abbott Laboratories
TABLE 51 Key Information – Medtronic PLC
TABLE 52 key Information – Boston Scientific Corporation
TABLE 53 Key Information – Integra LifeSciences Holdings Corporation
TABLE 54 key Information – Stryker Corporation
TABLE 55 Key Information – Axogen, Inc.
TABLE 56 Key Information – Synovis Micro Companies Alliance, Inc.
TABLE 57 Key Information – OrthoMed, Inc
TABLE 58 Key Information – Polyganics BV
TABLE 59 Key Information – Checkpoint Surgical Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Abbott Laboratories
FIG 5 Recent strategies and developments: Integra Lifesciences Corporation
FIG 6 Recent strategies and developments: Polyganics BV
FIG 7 Recent strategies and developments: Checkpoint Surgical, Inc.